HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $296,000 | -39.7% | 51,695 | -3.9% | 0.01% | -53.3% |
Q4 2021 | $491,000 | +20.3% | 53,804 | +41.0% | 0.03% | -6.2% |
Q3 2021 | $408,000 | +8.5% | 38,154 | +57.5% | 0.03% | 0.0% |
Q2 2021 | $376,000 | -18.3% | 24,229 | -14.7% | 0.03% | -23.8% |
Q1 2021 | $460,000 | -57.2% | 28,393 | -60.8% | 0.04% | -39.1% |
Q3 2020 | $1,074,000 | +160.0% | 72,449 | +158.0% | 0.07% | +137.9% |
Q2 2020 | $413,000 | -55.8% | 28,085 | -64.7% | 0.03% | -57.4% |
Q1 2020 | $935,000 | -16.5% | 79,631 | +67.1% | 0.07% | +3.0% |
Q4 2019 | $1,120,000 | -35.1% | 47,651 | -32.5% | 0.07% | -46.3% |
Q1 2019 | $1,726,000 | +154.6% | 70,639 | +230.0% | 0.12% | +141.2% |
Q3 2018 | $678,000 | -31.4% | 21,408 | -15.9% | 0.05% | -26.1% |
Q2 2018 | $989,000 | +5.2% | 25,456 | -51.0% | 0.07% | -33.0% |
Q4 2017 | $940,000 | +356.3% | 51,907 | +306.3% | 0.10% | +98.1% |
Q3 2017 | $206,000 | -41.6% | 12,776 | -52.5% | 0.05% | -7.1% |
Q4 2016 | $353,000 | +19.3% | 26,915 | +143.1% | 0.06% | +115.4% |
Q4 2015 | $296,000 | – | 11,072 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |